|Day's Range||53.47 - 54.45|
|52 Week Range||46.01 - 77.12|
|PE Ratio (TTM)||18.69|
|Dividend & Yield||1.56 (2.88%)|
|1y Target Est||N/A|
Combined sales for Januvia and Janumet were ~$1.3 billion for 1Q17, a ~5.0% fall from $1.4 billion in 1Q16.
If someone is looking for convincing arguments about the wildly publicized doom of the hedge fund business, they don’t need to look far beyond the 2017 list of the highest paid hedge fund managers compiled by Institutional Investors’ Alpha. According to the coveted magazine, 2016 was the year when the top-25 earning hedge fund managers […]
Bristol-Myers Squibb's (BMY) oncology and cardiovascular products were among the most prioritized brands in the company's total portfolio in 1Q17.